[
  {
    "ts": null,
    "headline": "UnitedHealth Group Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "UnitedHealth Group Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=37bda5cd5232a32a0ebf1116f43c27706904785f8fd3c62e42e11dcea2b5e319",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732033860,
      "headline": "UnitedHealth Group Inc. stock underperforms Tuesday when compared to competitors",
      "id": 131505585,
      "image": "",
      "related": "UNH",
      "source": "MarketWatch",
      "summary": "UnitedHealth Group Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=37bda5cd5232a32a0ebf1116f43c27706904785f8fd3c62e42e11dcea2b5e319"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Group Incorporated (UNH) Rose on Earnings Beat",
    "summary": "Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. All equity classes experienced good results in the third quarter. During the quarter, equity markets ended on a high note, with the S&P 500 achieving a 5.89% increase, bringing the full-year […]",
    "url": "https://finnhub.io/api/news?id=a29776a1ea80efab3b7b5576d3f230f8bd1fc2511693bc94fe4dec47dc49951a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732025927,
      "headline": "UnitedHealth Group Incorporated (UNH) Rose on Earnings Beat",
      "id": 131493242,
      "image": "https://media.zenfs.com/en/insidermonkey.com/c740e54fe5f56f1da027ee400791c870",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. All equity classes experienced good results in the third quarter. During the quarter, equity markets ended on a high note, with the S&P 500 achieving a 5.89% increase, bringing the full-year […]",
      "url": "https://finnhub.io/api/news?id=a29776a1ea80efab3b7b5576d3f230f8bd1fc2511693bc94fe4dec47dc49951a"
    }
  },
  {
    "ts": null,
    "headline": "Myriad Genetics price target lowered to $21 from $32 at Morgan Stanley",
    "summary": "Morgan Stanley lowered the firm’s price target on Myriad Genetics (MYGN) to $21 from $32 and keeps an Equal Weight rating on the shares. Q3 results came in slightly above the preliminary view as average selling price strength more than offset some volume softness, the analyst noted. UnitedHealth’s (UNH) decision to drop coverage of multi-gene behavioral health PGx tests equates annually to about $40M in revenue and about $30M in gross profit impact, notes the analyst, who adds that “broader payo",
    "url": "https://finnhub.io/api/news?id=16bfc63920413f54c103671ce8de648509bc589d46ae888a52a813163700f72f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732019236,
      "headline": "Myriad Genetics price target lowered to $21 from $32 at Morgan Stanley",
      "id": 131470796,
      "image": "https://media.zenfs.com/en/tipranks_452/373719bd4f9106065622fdb013c92607",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Morgan Stanley lowered the firm’s price target on Myriad Genetics (MYGN) to $21 from $32 and keeps an Equal Weight rating on the shares. Q3 results came in slightly above the preliminary view as average selling price strength more than offset some volume softness, the analyst noted. UnitedHealth’s (UNH) decision to drop coverage of multi-gene behavioral health PGx tests equates annually to about $40M in revenue and about $30M in gross profit impact, notes the analyst, who adds that “broader payo",
      "url": "https://finnhub.io/api/news?id=16bfc63920413f54c103671ce8de648509bc589d46ae888a52a813163700f72f"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth price target raised to $670 from $630 at Wells Fargo",
    "summary": "Wells Fargo analyst Stephen Baxter raised the firm’s price target on UnitedHealth (UNH) to $670 from $630 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist. Published first on TheFly – the ultimate source for real-time, market-moving breaking",
    "url": "https://finnhub.io/api/news?id=e95372cb6f0614e015c7d0ec24df71d01a1a9c32f2890aca324d55563a828a49",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732015238,
      "headline": "UnitedHealth price target raised to $670 from $630 at Wells Fargo",
      "id": 131493245,
      "image": "",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Wells Fargo analyst Stephen Baxter raised the firm’s price target on UnitedHealth (UNH) to $670 from $630 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist. Published first on TheFly – the ultimate source for real-time, market-moving breaking",
      "url": "https://finnhub.io/api/news?id=e95372cb6f0614e015c7d0ec24df71d01a1a9c32f2890aca324d55563a828a49"
    }
  },
  {
    "ts": null,
    "headline": "Walt Disney, Sherwin-Williams Co. share losses lead Dow's nearly 200-point fall",
    "summary": "Walt Disney, Sherwin-Williams Co. share losses lead Dow's nearly 200-point fall",
    "url": "https://finnhub.io/api/news?id=13c780ea8ad94fc0adb9fda9d65fba8d177298cde4b9d6359d9e1f63d601db91",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732013160,
      "headline": "Walt Disney, Sherwin-Williams Co. share losses lead Dow's nearly 200-point fall",
      "id": 131472873,
      "image": "",
      "related": "UNH",
      "source": "MarketWatch",
      "summary": "Walt Disney, Sherwin-Williams Co. share losses lead Dow's nearly 200-point fall",
      "url": "https://finnhub.io/api/news?id=13c780ea8ad94fc0adb9fda9d65fba8d177298cde4b9d6359d9e1f63d601db91"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For November",
    "summary": "November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced.",
    "url": "https://finnhub.io/api/news?id=17b2ae374f72b898be1e13a220d648b578b5b9ae1db05e9f4365ec93e3d05504",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732007700,
      "headline": "IXJ: Healthcare Sector Dashboard For November",
      "id": 131471159,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/688000635/image_688000635.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced.",
      "url": "https://finnhub.io/api/news?id=17b2ae374f72b898be1e13a220d648b578b5b9ae1db05e9f4365ec93e3d05504"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Select Health Care Portfolio Q3 2024 Fund Review",
    "summary": "For Q3 2024, the Fidelity Select Health Care Portfolio fund gained 9.48%, outperforming the MSCI sector index. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=f19c540ed18a1c2f912d6ff2c1c5be2a7f351bca6a9d716c8a57b31d84916382",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731993000,
      "headline": "Fidelity Select Health Care Portfolio Q3 2024 Fund Review",
      "id": 131467028,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1849023174/image_1849023174.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "For Q3 2024, the Fidelity Select Health Care Portfolio fund gained 9.48%, outperforming the MSCI sector index. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=f19c540ed18a1c2f912d6ff2c1c5be2a7f351bca6a9d716c8a57b31d84916382"
    }
  }
]